UMB Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

UMB Bank’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.9K	Buy	681 +91	+15%	+$2.17K	﹤0.01%	1665
2025 Q4	$13.8K	Buy	590 +160	+37%	+$3.56K	﹤0.01%	1692
2025 Q3	$8.47K	Buy	430 +3	+0.7%	+$62	﹤0.01%	1742
2025 Q2	$9.27K	Buy	427 +10	+2%	+$236	﹤0.01%	1629
2025 Q1	$10.1K	Buy	417 +135	+48%	+$3.04K	﹤0.01%	1545
2024 Q4	$5.88K	Hold	282	–	–	﹤0.01%	1652
2024 Q3	$5.61K	Buy	282 +140	+99%	+$2.6K	﹤0.01%	1690
2024 Q2	$2.2K	Buy	142 +92	+184%	+$1.43K	﹤0.01%	1740
2024 Q1	$797	Buy	+50	New	+$753	﹤0.01%	1850

Other funds holding CPRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM